BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23291480)

  • 1. The role of biliary epithelial cells in the immunopathogenesis of non-suppurative destructive cholangitis in murine hepatic graft-versus-host disease.
    Vierling JM; Hreha G; Wang H; Braun M
    Trans Am Clin Climatol Assoc; 2011; 122():326-35. PubMed ID: 21686235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.
    Erice O; Munoz-Garrido P; Vaquero J; Perugorria MJ; Fernandez-Barrena MG; Saez E; Santos-Laso A; Arbelaiz A; Jimenez-Agüero R; Fernandez-Irigoyen J; Santamaria E; Torrano V; Carracedo A; Ananthanarayanan M; Marzioni M; Prieto J; Beuers U; Oude Elferink RP; LaRusso NF; Bujanda L; Marin JJG; Banales JM
    Hepatology; 2018 Apr; 67(4):1420-1440. PubMed ID: 28922472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor alpha-mediated mitochondrial damage in intrahepatic bile duct epithelial cells leading to the pathogenesis of primary biliary cholangitis.
    Liang M; Ye S; Jing R; Zhu B; Yuan W; Chu X; Li Y; Zhang W
    Environ Toxicol; 2023 Dec; 38(12):2803-2818. PubMed ID: 37740728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zebrafish ppp1r21 mutant as a model for the study of primary biliary cholangitis.
    Wu C; Zhang W; Luo Y; Cheng C; Wang X; Jiang Y; Li S; Luo L; Yang Y
    J Genet Genomics; 2023 Dec; 50(12):1004-1013. PubMed ID: 37271428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.
    Cordell HJ; Fryett JJ; Ueno K; Darlay R; Aiba Y; Hitomi Y; Kawashima M; Nishida N; Khor SS; Gervais O; Kawai Y; Nagasaki M; Tokunaga K; Tang R; Shi Y; Li Z; Juran BD; Atkinson EJ; Gerussi A; Carbone M; Asselta R; Cheung A; de Andrade M; Baras A; Horowitz J; Ferreira MAR; Sun D; Jones DE; Flack S; Spicer A; Mulcahy VL; Byan J; Han Y; Sandford RN; Lazaridis KN; Amos CI; Hirschfield GM; Seldin MF; Invernizzi P; Siminovitch KA; Ma X; Nakamura M; Mells GF; ; ; ; ; ; ;
    J Hepatol; 2021 Sep; 75(3):572-581. PubMed ID: 34033851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Biliary Cholangitis: Pathophysiology.
    Houri I; Hirschfield GM
    Clin Liver Dis; 2024 Feb; 28(1):79-92. PubMed ID: 37945164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors in secondary obstructive cholangiopathy.
    Miranda-Díaz AG; Alonso-Martínez H; Hernández-Ojeda J; Arias-Carvajal O; Rodríguez-Carrizalez AD; Román-Pintos LM
    Gastroenterol Res Pract; 2011; 2011():265093. PubMed ID: 22114589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of biliary injury and altered bile acid metabolism.
    Mariotti V; Strazzabosco M; Fabris L; Calvisi DF
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1254-1261. PubMed ID: 28709963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases.
    Bernardini G; Antonangeli F; Bonanni V; Santoni A
    Front Immunol; 2016; 7():402. PubMed ID: 27766097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK Cell Subtypes as Regulators of Autoimmune Liver Disease.
    Jiao G; Wang B
    Gastroenterol Res Pract; 2016; 2016():6903496. PubMed ID: 27462349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity in the pathogenesis of cholangiopathy: a recent update.
    Harada K; Nakanuma Y
    Inflamm Allergy Drug Targets; 2012 Dec; 11(6):478-83. PubMed ID: 22920631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia.
    Okamura A; Harada K; Nio M; Nakanuma Y
    J Clin Pathol; 2013 Feb; 66(2):99-108. PubMed ID: 23162109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary innate immunity in the pathogenesis of biliary diseases.
    Harada K; Nakanuma Y
    Inflamm Allergy Drug Targets; 2010 Jun; 9(2):83-90. PubMed ID: 20402650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of biliary tract injury in primary biliary cirrhosis].
    Ishibashi H; Shimoda S
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(6):455-62. PubMed ID: 23291480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells.
    Shimoda S; Harada K; Niiro H; Yoshizumi T; Soejima Y; Taketomi A; Maehara Y; Tsuneyama K; Nakamura M; Komori A; Migita K; Nakanuma Y; Ishibashi H; Selmi C; Gershwin ME
    Hepatology; 2008 Mar; 47(3):958-65. PubMed ID: 18181218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis.
    Shimoda S; Harada K; Niiro H; Shirabe K; Taketomi A; Maehara Y; Tsuneyama K; Nakanuma Y; Leung P; Ansari AA; Gershwin ME; Akashi K
    Hepatology; 2011 Apr; 53(4):1270-81. PubMed ID: 21400555
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.